Steven Edginton
Family · Colorado Springs, CONPI 1598064842
Payments from drug & device makers
Across 213 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$529
- Novo Nordisk$417
- Esperion Therapeutics, Inc.$392
- Amgen$271
- Johnson & Johnson$265
- Boehringer Ingelheim$257
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,695100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $529 |
| Novo Nordisk | 22 | $417 |
| Esperion Therapeutics, Inc. | 23 | $392 |
| Amgen | 17 | $271 |
| Johnson & Johnson | 17 | $265 |
| Boehringer Ingelheim | 13 | $257 |
| Lilly USA, LLC | 18 | $248 |
| Pfizer | 9 | $145 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $136 |
| AstraZeneca | 8 | $134 |
| Seqirus USA Inc | 4 | $76 |
| Inspire Medical Systems, Inc. | 1 | $62 |
| Novartis | 3 | $62 |
| Merck | 3 | $50 |
| GSK | 3 | $48 |
| Hologic Sales And Service, LLC | 2 | $47 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Nestle Healthcare Nutrition Inc. | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Exact Sciences | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Sanofi | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| Bausch Health US, LLC | 1 | $25 |
| Medtronic | 1 | $25 |
| Optinose US, Inc. | 1 | $23 |
| Bayer | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Cranial Technologies, Inc | 1 | $19 |
| Lifescan, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Inogen, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$3,695 in reported general payments places this provider in the 90th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $79,174 |
| JardianceEmpagliflozin | 46 | $48,788 |
| EliquisApixaban | 35 | $28,399 |
| MounjaroTirzepatide | 21 | $22,595 |
| FarxigaDapagliflozin Propanediol | 16 | $15,178 |
| TrulicityDulaglutide | 11 | $15,077 |
| NexlizetBempedoic Acid/Ezetimibe | 13 | $14,398 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $3,200 |
| Ipratropium Bromide | 55 | $2,040 |
| SynthroidLevothyroxine Sodium | 33 | $1,908 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,564 |
| Rosuvastatin Calcium | 176 | $1,563 |
| Tamsulosin Hcl | 71 | $1,302 |
| Ezetimibe | 50 | $1,283 |
| Potassium Chloride | 16 | $1,182 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $417 | $79,17445 claims |
| Boehringer IngelheimJardiance | $257 | $48,78846 claims |
| Lilly USA, LLCMounjaro, Trulicity | $248 | $37,67232 claims |
| PfizerEliquis | $145 | $28,39935 claims |
| AstraZenecaFarxiga, Symbicort | $134 | $18,37730 claims |
| Esperion Therapeutics, Inc.Nexlizet | $392 | $14,39813 claims |
| AbbVieSynthroid | $529 | $1,90833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,182 family providers in Colorado.
Other family in Colorado Springs
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- Jeannette LillerColorado Springs$74K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Barbara ChamnessColorado Springs$15K
- Julie UnruhColorado Springs$14K
- Lisa HutchcraftColorado Springs$13K
- Kristin SekelskyColorado Springs$10K
- Leandrea TzitzicasColorado Springs$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.